Tuberculosis and Lung Diseases Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
BMJ. 2022 Jul 27;378:e069679. doi: 10.1136/bmj-2021-069679.
To report the global, regional, and national burden of chronic obstructive pulmonary disease (COPD) and its attributable risk factors between 1990 and 2019, by age, sex, and sociodemographic index.
Systematic analysis.
Global Burden of Disease Study 2019.
Data on the prevalence, deaths, and disability adjusted life years (DALYs) of COPD, and its attributable risk factors, were retrieved from the Global Burden of Disease 2019 project for 204 countries and territories, between 1990 and 2019. The counts and rates per 100 000 population, along with 95% uncertainty intervals, were presented for each estimate.
In 2019, 212.3 million prevalent cases of COPD were reported globally, with COPD accounting for 3.3 million deaths and 74.4 million DALYs. The global age standardised point prevalence, death, and DALY rates for COPD were 2638.2 (95% uncertainty intervals 2492.2 to 2796.1), 42.5 (37.6 to 46.3), and 926.1 (848.8 to 997.7) per 100 000 population, which were 8.7%, 41.7%, and 39.8% lower than in 1990, respectively. In 2019, Denmark (4299.5), Myanmar (3963.7), and Belgium (3927.7) had the highest age standardised point prevalence of COPD. Egypt (62.0%), Georgia (54.9%), and Nicaragua (51.6%) showed the largest increases in age standardised point prevalence across the study period. In 2019, Nepal (182.5) and Japan (7.4) had the highest and lowest age standardised death rates per 100 000, respectively, and Nepal (3318.4) and Barbados (177.7) had the highest and lowest age standardised DALY rates per 100 000, respectively. In men, the global DALY rate of COPD increased up to age 85-89 years and then decreased with advancing age, whereas for women the rate increased up to the oldest age group (≥95 years). Regionally, an overall reversed V shaped association was found between sociodemographic index and the age standardised DALY rate of COPD. Factors contributing most to the DALYs rates for COPD were smoking (46.0%), pollution from ambient particulate matter (20.7%), and occupational exposure to particulate matter, gases, and fumes (15.6%).
Despite the decreasing burden of COPD, this disease remains a major public health problem, especially in countries with a low sociodemographic index. Preventive programmes should focus on smoking cessation, improving air quality, and reducing occupational exposures to further reduce the burden of COPD.
报告 1990 年至 2019 年期间全球、区域和国家慢性阻塞性肺疾病(COPD)的负担及其归因风险因素,按年龄、性别和社会人口指数进行分层。
系统分析。
2019 年全球疾病负担研究。
COPD 的患病率、死亡人数和残疾调整生命年(DALY)及其归因风险因素的数据来自 204 个国家和地区的 2019 年全球疾病负担研究项目,时间跨度为 1990 年至 2019 年。每个估计值的计数和每 10 万人的比率及其 95%置信区间都进行了呈现。
2019 年,全球有 2.123 亿例 COPD 现患病例,COPD 导致 330 万人死亡,7440 万人残疾调整生命年丧失。全球年龄标准化点患病率、死亡率和 DALY 率为 2638.2(95%置信区间为 2492.2 至 2796.1)、42.5(37.6 至 46.3)和 926.1(848.8 至 997.7)/100000 人,与 1990 年相比,分别降低了 8.7%、41.7%和 39.8%。2019 年,丹麦(4299.5)、缅甸(3963.7)和比利时(3927.7)的 COPD 年龄标准化点患病率最高。埃及(62.0%)、格鲁吉亚(54.9%)和尼加拉瓜(51.6%)在整个研究期间的年龄标准化点患病率增幅最大。2019 年,尼泊尔(182.5)和日本(7.4)的年龄标准化死亡率最高和最低,分别为每 100000 人 182.5 和 7.4;尼泊尔(3318.4)和巴巴多斯(177.7)的年龄标准化 DALY 率最高和最低,分别为每 100000 人 3318.4 和 177.7。在男性中,COPD 的全球 DALY 率在 85-89 岁之间增加,然后随着年龄的增长而下降,而在女性中,该比率在年龄最大的组(≥95 岁)中增加。从区域来看,社会人口指数与 COPD 的年龄标准化 DALY 率之间存在总体相反的 V 形关联。对 COPD 的 DALY 率贡献最大的因素是吸烟(46.0%)、环境细颗粒物污染(20.7%)和职业接触颗粒物、气体和烟雾(15.6%)。
尽管 COPD 的负担有所减轻,但这仍是一个主要的公共卫生问题,尤其是在社会人口指数较低的国家。预防计划应侧重于戒烟、改善空气质量和减少职业接触,以进一步降低 COPD 的负担。